These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

320 related items for PubMed ID: 11007237

  • 1. Need for validation of clinical decision aids: use of the AST/ALT ratio in predicting cirrhosis in chronic hepatitis C.
    Imperiale TF, Said AT, Cummings OW, Born LJ.
    Am J Gastroenterol; 2000 Sep; 95(9):2328-32. PubMed ID: 11007237
    [Abstract] [Full Text] [Related]

  • 2. AST/ALT ratio predicts cirrhosis in patients with chronic hepatitis C virus infection.
    Sheth SG, Flamm SL, Gordon FD, Chopra S.
    Am J Gastroenterol; 1998 Jan; 93(1):44-8. PubMed ID: 9448172
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Comparison of various noninvasive serum markers of liver fibrosis in chronic viral liver disease].
    Kim SM, Sohn JH, Kim TY, Roh YW, Eun CS, Jeon YC, Han DS, Oh YH.
    Korean J Hepatol; 2009 Dec; 15(4):454-63. PubMed ID: 20037264
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Comparison and validation of simple noninvasive tests for prediction of fibrosis in chronic hepatitis C.
    Lackner C, Struber G, Liegl B, Leibl S, Ofner P, Bankuti C, Bauer B, Stauber RE.
    Hepatology; 2005 Jun; 41(6):1376-82. PubMed ID: 15915455
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The 1-year and 3-month prognostic utility of the AST/ALT ratio and model for end-stage liver disease score in patients with viral liver cirrhosis.
    Giannini E, Botta F, Testa E, Romagnoli P, Polegato S, Malfatti F, Fumagalli A, Chiarbonello B, Risso D, Testa R.
    Am J Gastroenterol; 2002 Nov; 97(11):2855-60. PubMed ID: 12425560
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Validation of three non-invasive markers in assessing the severity of liver fibrosis in chronic hepatitis C.
    Shaikh S, Memon MS, Ghani H, Baloch GH, Jaffery M, Shaikh K.
    J Coll Physicians Surg Pak; 2009 Aug; 19(8):478-82. PubMed ID: 19651008
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The AST/ALT ratio as an indicator of cirrhosis in patients with PBC.
    Nyblom H, Björnsson E, Simrén M, Aldenborg F, Almer S, Olsson R.
    Liver Int; 2006 Sep; 26(7):840-5. PubMed ID: 16911467
    [Abstract] [Full Text] [Related]

  • 18. Performance of noninvasive markers for liver fibrosis is reduced in chronic hepatitis C with normal transaminases.
    Sebastiani G, Vario A, Guido M, Alberti A.
    J Viral Hepat; 2008 Mar; 15(3):212-8. PubMed ID: 18179453
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Simple blood tests can predict compensated liver cirrhosis in patients with chronic hepatitis C.
    Luo JC, Hwang SJ, Chang FY, Chu CW, Lai CR, Wang YJ, Lee PC, Tsay SH, Lee SD.
    Hepatogastroenterology; 2002 Mar; 49(44):478-81. PubMed ID: 11995477
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.